ns in February for the clinical application of new biomedical technologies, stipulating that clini
cal research that involves human trials, including gene editing, stem cells, organ transplants be
tween species and assisted reproductive technologies, must secure the approval of the commission in advance.
Under the draft, which is yet to be adopted, violators may face punishments including fines, revocation of business permits or criminal charges.
The commission this year will complete its revision of an existing r
egulation on ethical inspection of human-related biomedical research that was adopted in 2016.
Authorities are also considering establishing a national ethics co
mmittee that supervises life science technologies and researchers to ensure compliance wi
th ethical standards, Huang Jiefu, former vice-minister of health, told China Daily in an earlier interview.